US Stock MarketDetailed Quotes
CPRX Catalyst Pharmaceuticals
- 21.265
- +0.445+2.14%
Trading Nov 19 11:37 ET
2.54BMarket Cap18.02P/E (TTM)
21.270High20.760Low182.65KVolume20.810Open20.820Pre Close3.85MTurnover0.17%Turnover Ratio33.75P/E (Static)119.27MShares24.27052wk High3.84P/B2.25BFloat Cap13.00052wk Low--Dividend TTM105.92MShs Float24.270Historical High--Div YieldTTM2.45%Amplitude0.370Historical Low21.068Avg Price1Lot Size
About Catalyst Pharmaceuticals Company
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Company Profile
SymbolCPRX
Company NameCatalyst Pharmaceuticals
Listing DateNov 8, 2006
Issue Price6.00
Founded2002
CEOMr. Richard J. Daly
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address355 Alhambra Circle,Suite 801
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-305-420-3200
Company Executives
- Name
- Position
- Salary
- Richard J. Daly
- Director, President and Chief Executive Officer
- 14.08M
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 3.40M
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 2.51M
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 2.37M
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 2.15M
- Dr. David S. Tierney,M.D.
- Independent Director
- 370.99K
- Tamar Thompson
- Independent Director
- 610.43K
- Donald A. Denkhaus
- Independent Director
- 376.24K
- Charles B. O'Keeffe
- Lead Independent Director
- 397.24K
- Molly Harper
- Independent Director
- 363.12K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data